Technical Analysis for EKSO - Ekso Bionics Holdings, Inc.

Grade Last Price % Change Price Change
grade F 0.83 0.08% 0.00
EKSO closed up 0.08 percent on Wednesday, August 21, 2019, on 58 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical EKSO trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.08%
Wide Bands Range Expansion 0.08%
Oversold Stochastic Weakness 0.08%
1,2,3 Retracement Bearish Bearish Swing Setup -2.16%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.16%
Wide Bands Range Expansion -2.16%
Oversold Stochastic Weakness -2.16%

Older signals for EKSO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.
Prosthetics Robotics Assistive Technology
Is EKSO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 15 Ekso debuts next-gen exoskeleton; shares up 1% premarket
Aug 15 Ekso Bionics® Unveils the Next Generation Exoskeleton for Neurorehabilitation
Aug 15 The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
Aug 13 Do Institutions Own Shares In Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)?
Aug 5 82 Biggest Movers From Friday
Aug 2 Aphria leads healthcare gainers; Acorda Therapeutics and Ekso Bionics Holdings among losers
Aug 2 Ekso down 19% after Q2 results as growth remains elusive
Aug 2 Edited Transcript of EKSO earnings conference call or presentation 1-Aug-19 8:30pm GMT
Aug 2 Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2019 Results - Earnings Call Transcript
Aug 1 Ekso Bionics Holdings EPS beats by $0.04, misses on revenue
See more EKSO news...
Indicators
Indicator Value
52 Week High 2.81
52 Week Low 0.7701
Average Volume 338,440
200-Day Moving Average 1.747
50-Day Moving Average 1.1432
20-Day Moving Average 0.9627
10-Day Moving Average 0.8441
Average True Range 0.0622
ADX 51.88
+DI 8.1843
-DI 36.2563
Chandelier Exit (Long, 3 ATRs ) 1.0834
Chandelier Exit (Short, 3 ATRs ) 0.9567
Upper Bollinger Band 1.2717
Lower Bollinger Band 0.6537
Percent B (%b) 0.29
BandWidth 64.194453
MACD Line -0.1078
MACD Signal Line -0.1086
MACD Histogram 0.0008
Fundamentals Value
Market Cap 21.4 Million
Num Shares 25.8 Million
EPS -1.59
Price-to-Earnings (P/E) Ratio -0.52
Price-to-Sales 3.79
Price-to-Book 17.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.89
Resistance 3 (R3) 0.89 0.87 0.88
Resistance 2 (R2) 0.87 0.85 0.87 0.88
Resistance 1 (R1) 0.85 0.84 0.86 0.85 0.88
Pivot Point 0.82 0.82 0.83 0.83 0.82
Support 1 (S1) 0.81 0.81 0.82 0.81 0.78
Support 2 (S2) 0.78 0.80 0.78 0.78
Support 3 (S3) 0.76 0.78 0.78
Support 4 (S4) 0.77